Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05911555 · ClinicalTrials.gov registry record
Mucin Levels in Dry Eye and Normal Populations
A clinical trial, sponsored by ORA.
- Completed
- Registry status
- 34
- Enrollment target
NCT05911555: Completed study, sponsored by ORA.
NCT05911555 is a clinical trial that has completed, run by ORA. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05911555 has completed, sponsored by ORA.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate changes in ocular mucin levels in response to a drying environment in subjects with dry eye disease as well as patients who report no history of dry eye disease. It is expected that exposure to the dry environment will alter mucin levels in different ways when comparing the two groups.
Primary Outcome
Tears will be collected and mucin will be measured after subjects are exposed to the CAE.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2013-05 |
| Est. Completion | 2013-05 |
What the finished NCT05911555 record still lists
NCT05911555 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05911555 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05911555 about?
NCT05911555 is a clinical study titled "Mucin Levels in Dry Eye and Normal Populations". The purpose of this study is to evaluate changes in ocular mucin levels in response to a drying environment in subjects with dry eye disease as well as patients who report no history of dry eye disease. It is expected that exposure to the dry environment will alter mucin levels in different ways wh...
What is the current status of trial NCT05911555?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2013-05. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT05911555?
This trial is sponsored by ORA, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia